We’ve talked about the RECOVERY trial on the blog and podcast before. This is a UK based platform trial (more on this later) looking at patients admitted to hospital with Covid-19. It’s an open label RCT that was developed out of the ASAP trial​1​. ASAP was (still is) a hibernating trial​2​ that was designed to … Continue reading The RECOVERY platform trial: No benefit to Hydroxychloroquine in Covid-19. St Emlyn’s